Literature DB >> 14729348

Structure of the haemagglutinin-neuraminidase from human parainfluenza virus type III.

Michael C Lawrence1, Natalie A Borg, Victor A Streltsov, Patricia A Pilling, V Chandana Epa, Joseph N Varghese, Jennifer L McKimm-Breschkin, Peter M Colman.   

Abstract

The three-dimensional structure of the haemagglutinin-neuraminidase (HN) from a human parainfluenza virus is described at ca 2.0 A resolution, both in native form and in complex with three substrate analogues. In support of earlier work on the structure of the homologous protein from the avian pathogen Newcastle disease virus (NDV), we observe a dimer of beta-propellers and find no evidence for spatially separated sites performing the receptor-binding and neuraminidase functions of the protein. As with the NDV HN, the active site of the HN of parainfluenza viruses is structurally flexible, suggesting that it may be able to switch between a receptor-binding state and a catalytic state. However, in contrast to the NDV structures, we observe no ligand-induced structural changes that extend beyond the active site and modify the dimer interface.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14729348     DOI: 10.1016/j.jmb.2003.11.032

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  117 in total

Review 1.  Modes of paramyxovirus fusion: a Henipavirus perspective.

Authors:  Benhur Lee; Zeynep Akyol Ataman
Journal:  Trends Microbiol       Date:  2011-04-20       Impact factor: 17.079

2.  Amino acid substitutions contributing to α2,6-sialic acid linkage binding specificity of human parainfluenza virus type 3 hemagglutinin-neuraminidase.

Authors:  Keijo Fukushima; Tadanobu Takahashi; Hiroo Ueyama; Masahiro Takaguchi; Seigo Ito; Kenta Oishi; Akira Minami; Erika Ishitsubo; Hiroaki Tokiwa; Toru Takimoto; Takashi Suzuki
Journal:  FEBS Lett       Date:  2015-04-11       Impact factor: 4.124

3.  Mutation at residue 523 creates a second receptor binding site on human parainfluenza virus type 1 hemagglutinin-neuraminidase protein.

Authors:  Tatiana Bousse; Toru Takimoto
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

4.  Paramyxovirus receptor-binding molecules: engagement of one site on the hemagglutinin-neuraminidase protein modulates activity at the second site.

Authors:  Matteo Porotto; Micaela Fornabaio; Olga Greengard; Matthew T Murrell; Glen E Kellogg; Anne Moscona
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

5.  Refolding of a paramyxovirus F protein from prefusion to postfusion conformations observed by liposome binding and electron microscopy.

Authors:  Sarah A Connolly; George P Leser; Hsien-Shen Yin; Theodore S Jardetzky; Robert A Lamb
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-08       Impact factor: 11.205

6.  A second receptor binding site on human parainfluenza virus type 3 hemagglutinin-neuraminidase contributes to activation of the fusion mechanism.

Authors:  Matteo Porotto; Micaela Fornabaio; Glen E Kellogg; Anne Moscona
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

7.  Paramyxoviruses: different receptors - different mechanisms of fusion.

Authors:  Ronald M Iorio; Paul J Mahon
Journal:  Trends Microbiol       Date:  2008-03-17       Impact factor: 17.079

8.  A histidine switch in hemagglutinin-neuraminidase triggers paramyxovirus-cell membrane fusion.

Authors:  Anuja Krishnan; Santosh K Verma; Prashant Mani; Rahul Gupta; Suman Kundu; Debi P Sarkar
Journal:  J Virol       Date:  2008-12-03       Impact factor: 5.103

9.  Disruption of the Dimer-Dimer Interaction of the Mumps Virus Attachment Protein Head Domain, Aided by an Anion Located at the Interface, Compromises Membrane Fusion Triggering.

Authors:  Marie Kubota; Iori Okabe; Shin-Ichi Nakakita; Ayako Ueo; Yuta Shirogane; Yusuke Yanagi; Takao Hashiguchi
Journal:  J Virol       Date:  2020-01-06       Impact factor: 5.103

10.  N-linked glycan at residue 523 of human parainfluenza virus type 3 hemagglutinin-neuraminidase masks a second receptor-binding site.

Authors:  Vasiliy P Mishin; Makiko Watanabe; Garry Taylor; John Devincenzo; Michael Bose; Allen Portner; Irina V Alymova
Journal:  J Virol       Date:  2010-01-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.